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Arenaviruses initiate infection by delivering a transcriptionally competent
ribonucleoprotein (RNP) complex into the cytosol of host cells. The arenavirus RNP consists of the large (L) RNA-dependent RNA polymerase (RdRP) bound to a nucleoprotein
(NP)-encapsidated genomic RNA (viral RNA [vRNA]) template. During transcription and
replication, L must transiently displace RNA-bound NP to allow for template access into
the RdRP active site. Concomitant with RNA replication, new subunits of NP must be
added to the nascent complementary RNAs (cRNA) as they emerge from the product
exit channel of L. Interactions between L and NP thus play a central role in arenavirus
gene expression. We developed an approach to purify recombinant functional RNPs
from mammalian cells in culture using a synthetic vRNA and afﬁnity-tagged L and NP.
Negative-stain electron microscopy of puriﬁed RNPs revealed they adopt diverse and
ﬂexible structures, like RNPs of other Bunyavirales members. Monodispersed L-NP and
trimeric ring-like NP complexes were also obtained in excess of ﬂexible RNPs, suggesting
that these heterodimeric structures self-assemble in the absence of suitable RNA templates. This work allows for further biochemical analysis of the interaction between arenavirus L and NP proteins and provides a framework for future high-resolution structural
analyses of this replication-associated complex.
IMPORTANCE Arenaviruses are rodent-borne pathogens that can cause severe disease in
humans. All arenaviruses begin the infection cycle with delivery of the virus replication
machinery into the cytoplasm of the host cell. This machinery consists of an RNA-dependent RNA polymerase—which copies the viral genome segments and synthesizes all
four viral mRNAs—bound to the two nucleoprotein-encapsidated genomic RNAs. How
this complex assembles remains a mystery. Our ﬁndings provide direct evidence for the
formation of diverse intracellular arenavirus replication complexes using puriﬁcation
strategies for the polymerase, nucleoprotein, and genomic RNA of Machupo virus, which
causes Bolivian hemorrhagic fever in humans. We demonstrate that the polymerase and
nucleoprotein assemble into higher-order structures within cells, providing a model for
the molecular events of arenavirus RNA synthesis. These ﬁndings provide a framework
for probing the architectures and functions of the arenavirus replication machinery and
thus advancing antiviral strategies targeting this essential complex.
KEYWORDS arenavirus, Machupo virus, RNA-dependent RNA polymerase, gene

expression, negative-strand RNA virus, nucleoprotein, replication, ribonucleoprotein
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A

renaviruses (genus Mammarenavirus, family Arenaviridae, order Bunyavirales) are responsible for sporadic outbreaks of rodent-borne hemorrhagic fevers in humans.
Notable examples include Lassa fever virus (LASV), which is responsible for an estimated
5,000 to 10,000 deaths, annually (1), and the Junin, Machupo (MACV), and Guanarito
viruses, which cause Argentine, Bolivian, and Venezuelan hemorrhagic fevers, respectively (2). Lymphocytic choriomeningitis virus (LCMV), a model for arenavirus biology
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and mapping of the cellular immune responses, is globally seroprevalent and responsible for febrile illness, aseptic meningitis, neonatal disease, and multiple organ failure in
transplant patients (3–9). Although promising vaccine candidates (10–13) and therapeutic treatments (14–16) have been developed to combat arenavirus diseases, to date there
are limited effective intervention strategies for infected individuals.
The arenavirus genome consists of two negative-strand RNA segments encoding four
viral proteins: a large (L) RNA-dependent RNA polymerase (RdRP) and matrix protein (Z)
within the larger RNA segment, and an RNA-binding nucleoprotein (NP) and glycoprotein precursor (GPC) within the smaller RNA segment (Fig. 1A). The genome-sense RNAs
(viral RNAs [vRNAs]) are fully encapsidated by NP subunits and bound at both genome
termini by L to form pseudocircularized ribonucleoprotein (RNP) complexes (17–19).
Genomic RNPs (viral RNPs [vRNPs]) are enveloped by a lipid bilayer decorated with
mature viral glycoproteins, forming the infectious arenavirus virion.
Upon glycoprotein-mediated virion fusion within acidiﬁed endosomes, the packaged
vRNPs are delivered into the host cytoplasm to initiate viral gene expression and genome replication. Viral mRNA synthesis begins with cap-snatching, whereby the L capbinding domain recognizes 59 m7GpppN cap structures of host mRNAs for L-mediated
endonucleolytic cleavage and priming of transcription initiation (20–29). As L transcribes
along the vRNA, NP is transiently displaced to allow template access into the RdRP catalytic site. The growing mRNA is not bound by NP and terminates at highly structured
intergenic regions (IGRs) between the two open reading frames (ORFs) of the vRNA segments (Fig. 1A) (28, 30–36).
L and NP mRNAs are the ﬁrst transcripts synthesized from the large and small RNA
segments, respectively (Fig. 1A). L and NP, provided with a suitable RNA template, are
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FIG 1 Arenavirus genome organization and gene expression strategies. (A) Illustration of the mammarenavirus genome
and sequential stages of transcription and replication during the infection cycle. The sequential order of primary
transcription (L and NP mRNA synthesis), genome replication (cRNA synthesis from vRNA template), and secondary
transcription (Z and GPC mRNA synthesis) are listed numerically on the left-hand side. Viral ORFs in the expressed coding
orientation are shown on corresponding template RNAs as colored boxes, whereas the antisense ORFs are illustrated as
empty white boxes with a dashed outline. 59 cap structures are shown as rounded-end caps on the mRNAs and are
colored blue to indicate nonviral sequences acquired via cap snatching. The intergenic regions (IGRs) of each RNA
segment are illustrated between the ORFs as a structured hairpin cartoon. (B) Linear map of the Machupo virus (MACV) L
protein. The C-terminal cap-binding domain (CBD) and N-terminal cap-dependent endonuclease (EndoN) are shown in
dark blue. The central RNA-dependent RNA polymerase (RdRP) domain is shown in red. The introduced afﬁnity tags
described in this study are shown as colored regions at the C terminus of L. The position of the mutated residues
(SDD1328AAA) for the catalytically inactive mutant of L (LSDD) is shown in dark red.
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the minimal transactivating factors required to initiate arenavirus genome replication
(34, 37, 38). After a single round of vRNA copying into antigenomic cRNA, a secondary
round of transcription is required for expression of the Z and GPC mRNAs. Z directly
mediates catalytic shutdown of L activity (39–44), and GPC is required for infection of
new cells. cRNAs are also encapsidated by NP to form cRNPs; however, these replication intermediates are selectively excluded from budding virions (45–50).
Individual NP subunits fold into a two-lobed structure with deﬁned N- and C-terminal functional domains. Each NP monomer binds 6 to 7 nucleotides (nt) of RNA via positively charged residues in a groove formed by the N-terminal domain (51–53). RNA
binding is controlled by a gating mechanism, requiring a switch from “closed” to
“open” conformations and removal of obstructing alpha helices from the binding
pocket to allow for RNA recognition (52, 54). RNA binding induces rearrangement of
the NP C terminus, allowing for head-to-tail NP oligomerization along the RNA (55).
The C-terminal region of NP is responsible for RNP incorporation into budding virions
at the cell membrane via binding of Z (55, 56). Binding of the highly structured IGR
sequences by NP is thought to suppress L termination within this region during mRNA
synthesis (28, 35, 36), further underscoring the essential role of NP in arenavirus transcription and replication (34). Arenavirus NP is phosphorylated by a virion-associated
host kinase (57), and transient phosphorylation of a conserved threonine residue in the
RNA binding domain regulates replication-transcription complex (RTC) puncta formation in the host cell cytoplasm (58, 59).
Besides encapsidation of vRNA and cRNA segments, arenavirus NPs have additional
effector functions during infection—primarily evasion of the innate immune responses
of the cell. NP contains a C-terminal 39!59 DEDDh exonuclease (ExoN) fold with speciﬁcity for immunostimulatory double-stranded RNAs (dsRNAs) of viral origin (53, 54, 60–63).
Degradation of dsRNAs—pathogen-associated molecular patterns (PAMPs) recognized
by infected host cells as robust inducers of innate immune signaling pathways—
prevents antiviral signaling by cytosolic RNA sensors such as retinoic acid-inducible gene
I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5) (64–66). The NP ExoN
of Old World mammarenaviruses (i.e., LASV) eliminates immunostimulatory dsRNAs from
infected cells more efﬁciently than that of New World mammarenaviruses (e.g., MACV
and Junin virus), revealing a divergence in the immune-evading functions of NP (67, 68),
possibly reﬂecting fundamental differences in the ExoN activity of some viral NPs.
In agreement with this, the isolated C-terminal domain of the Junin virus NP does not
exhibit ExoN activity in vitro (69).
As the sole protective coating for viral genomic and antigenomic RNA templates,
the functions of negative-strand RNA virus (NSV) nucleoproteins are tightly linked to
the activities of the viral polymerase. An afﬁnity balance is required between polymerase-nucleoprotein and nucleoprotein-RNA binding and the ability of the polymerase to
displace nucleoprotein subunits from the RNA during elongation. Arenavirus L can
interact with NP indirectly via vRNA scaffolds and by direct binding (70–73). However,
the precise mechanisms and biological signiﬁcance of these interactions remain almost
entirely unclear.
The subcellular complexes formed by L and NP during arenavirus infections remain
unknown. Currently, our structural understanding of the arenavirus RTC is limited to
electron microscopy (EM) observations of virion-associated RNPs. Here, we provide
insight into the diverse intracellular structures formed by the polymerase and nucleoprotein of Machupo virus by reconstitution of functional MACV RNPs in hamster cells.
MACV L and NP with engineered afﬁnity tags assemble to form replication- and transcription-competent RNPs within cells. These complexes were puriﬁed and characterized by negative-stain EM. The MACV complexes adopt diverse structures ranging from
monomeric L-NP particles, homotrimeric NP ring-like assemblies, and higher-order ﬂexible ﬁlamentous nucleocapsids. These ﬁndings provide the ﬁrst structural insights into
the subcellular organization of actively replicating arenavirus L and NP subunits.
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Moreover, these ﬁndings highlight the utility of such reconstituted RNP systems for
studying the replication machinery of highly pathogenic mammarenaviruses.
RESULTS
Afﬁnity-tagged MACV L and NP assemble into functional RNPs. To isolate
actively replicating and transcribing MACV L from relevant host cells, we adapted our
previously developed T7 RNA polymerase (T7 RNAP)-driven minireplicon system to
incorporate afﬁnity tag epitopes into the L polypeptide (74) (Fig. 1B). This system relies
on expression of a modiﬁed MACV small RNA segment, with enhanced green ﬂuorescent protein (eGFP) replacing the antisense GPC ORF (Fig. 2A). Consequently, when
expressed with MACV L in trans, eGFP production is an indicator of L-mediated RNA
synthesis activity (74). Insect cell-expressed MACV L retains in vitro promoter initiation
and elongation activities with added C-terminal afﬁnity tags (39, 74, 75). Thus, we reasoned that similar L modiﬁcations could be amenable for the cell-based replicon system and afﬁnity puriﬁcation of MACV L from mammalian cells. The T7 RNAP expression
plasmids for wild-type and catalytically inactive (LSDD) MACV L were modiﬁed by incorporating Flag (DYKDDDDK) and 6His (HHHHHH) afﬁnity tags at the C terminus of L
for antibody and metal afﬁnity protein puriﬁcation, respectively (Fig. 1B). These added
epitopes did not affect the ability of L to recognize a minireplicon RNA as a suitable
template for replication and transcription within cells (Fig. 3A). Preliminary nickel afﬁnity puriﬁcations revealed that L could be isolated from RNP-expressing BSR-T7 cells in a
6His tag-dependent manner, with the most abundant copurifying protein migrating
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FIG 2 Expression of afﬁnity-tagged L in the MACV replicon system. (A) Schematic of the MACV minireplicon system. (B)
Analysis of minireplicon efﬁciency for L and NP expressed via different promoters (T7 or Pol II). Fluorescence microscopy
images of the eGFP-expressing cells are shown in the upper panel. Bright-ﬁeld images of infected and transfected cells in
the same ﬁeld of view are shown below. Cells transfected with a plasmid encoding T7 RNAP-driven eGFP are shown in the
right-hand column.

Journal of Virology

FIG 3 Further characterization of afﬁnity-tagged L and NP in the MACV RNP system. (A) Comparison of minireplicon replication and gene
expression mediated by afﬁnity-tagged MACV L in BSR-T7 cells. Bright-ﬁeld images of infected and transfected cells are shown in the left-hand
column. Fluorescence microscopy images of the eGFP-expressing cells in the same ﬁeld of view are shown in the right-hand column. Cells were
transfected with the minireplicon RNA (pMG) and nucleoprotein-expressing (pNP) plasmids, in combination with either wild-type L (untagged),
L with C-terminal Flag and 6His tags (tagged), catalytically inactive L with C-terminal tags (LSDD; tagged), or without any L-expressing plasmid
(2L). Cells transfected with a plasmid encoding T7 RNAP-driven eGFP expression are shown in the bottom panel. (B) Ni-NTA puriﬁcation of
MACV L from RNP-expressing cells. Cells in panel B were collected and subjected to metal ion afﬁnity puriﬁcation as described in Materials and
Methods. The sample fractions for each condition include the total cell lysate input (I), unbound ﬂowthrough (FT), eluted sample (E) in 0.25 M
imidazole, and residual bound proteins from the boiled Ni-NTA beads (B). Lane L contains the protein molecular weight ladder. (C) Further
characterization of the modiﬁed RNP system with Pol II-expressed L and NP with introduced afﬁnity tags. All cells in panels A and B were
infected with T7-expressing vaccinia virus for expression of the minireplicon RNA prior to plasmid transfection.
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at the approximate expected size of MACV NP (;63 kDa) (Fig. 3B). These results demonstrate that afﬁnity-tagged MACV L can function as a replicase and transcriptase in a
cell-based functional RNP system and that L predominantly coelutes with NP in a single-step metal ion afﬁnity puriﬁcation strategy.
Visually, the ﬂuorescence intensity and percentage of eGFP-positive cells were very
low compared to those of T7 RNAP-driven transfection controls (Fig. 3A), and this was
reﬂected in the low abundances of puriﬁed protein (Fig. 3B). This is in line with our original observations for the MACV RNP system, where low numbers of eGFP-positive cells
were observed relative to the total number of transfected cells (74). To address this issue,
we analyzed different promoter combinations for MACV L and NP expressed in trans
with the minireplicon RNA, as has been done for other arenavirus replicon systems (76,
77). Synthesis of transcripts by vaccinia virus-expressed T7 RNAP results in high levels of
cytoplasmic protein production in cells (78, 79), which could be problematic considering
the enzymatic activities and potential cytopathic effects of L and NP overexpression in
cells (EndoN, ExoN, RdRP, RNA binding, and 59 cap binding). We found that expression of
MACV L and NP from plasmids with host RNA polymerase II (Pol II) promoters resulted in
greater numbers of eGFP-positive cells (Fig. 2B). Under each condition, the cells were
infected with vaccinia virus to allow T7-driven expression of the minireplicon RNA.
Furthermore, we demonstrated that eGFP expression from the minireplicon is inhibited
by expression of a glutathione S-transferase (GST)-tagged MACV Z protein (Fig. 3C), as
described using the T7 RNAP-based original cell-based replicon system (39). Moreover,
expression of NP with a C-terminal V5 epitope tag (GKPIPNPLLGLDST) resulted in successful RNP replication and transcription, opening potential avenues for further afﬁnity
puriﬁcation or in-cell imaging of RTCs (Fig. 3C). Together, these ﬁndings demonstrate
that afﬁnity-tagged L and NP can assemble functional RNPs and operate more efﬁciently
when expressed from Pol II-driven promoters instead of promoters for vaccinia virusexpressed T7 RNAP.
NP immunoprecipitates with actively replicating L. We next attempted to optimize MACV L expression in RNP-expressing cells for subsequent puriﬁcation strategies.
Vaccinia virus-infected BSR-T7 cells were transfected with plasmids encoding T7 RNAPexpressed MACV minireplicon RNA (pMG) and transacting Pol II-expressed L and NP
(pL and pNP). The mass of pL transfected into cells was tested over a range of 0 to
8 m g. MACV L was immunoprecipitated from lysates of transfected cells using a rabbit
polyclonal antibody raised against recombinant L puriﬁed from insect cells. The relative
abundance of immunoprecipitated and cell lysate-associated L was determined
by SDS-PAGE, Coomassie blue staining, and immunoblotting. Immunoprecipitated
MACV L reached saturation at approximately 6 m g of transfected pL plasmid (Fig. 4).
Consistent with previous observations (Fig. 3B), we detected a discrete sharp band
migrating at the expected size of NP that coimmunoprecipitated with L (Fig. 4). L-NP
coimmunoprecipitation under these conditions was apparently saturated at 4 m g of
transfected pL plasmid (Fig. 4, right-hand gel, lane 5). These results further demonstrate that L and NP are associated, directly or indirectly, in cells in which functional
RNPs were reconstituted and can be isolated by different afﬁnity puriﬁcation
strategies.
NP-bound L forms monodispersed single particles. The copurifying L and NP samples isolated using anti-MACV L polyclonal antibodies (Fig. 4) had fewer copurifying background proteins than samples puriﬁed by metal ion afﬁnity chromatography (Fig. 3B).
Thus, we sought to utilize the C-terminal Flag epitope tag on MACV L for antibody-mediated afﬁnity puriﬁcation and competitive elution of the L-NP complex with soluble Flag
peptide. BSR-T7 cells were infected with T7 RNAP-expressing vaccinia virus, transfected
with the MACV RNP support plasmids, and monitored for eGFP expression for 72 h prior
to afﬁnity puriﬁcation. Cells expressing wild-type MACV L (pLWT) gradually accumulated
eGFP over 72 h, and this was absent in cells expressing the RdRP catalytic site mutant of L
(SDD1328AAA; pLSDD) (Fig. 5A). Cell lysates were harvested at 72 h posttransfection (hpt)
and subjected to nickel afﬁnity (N) and anti-Flag (F) afﬁnity puriﬁcations. Complexes were
November 2021 Volume 95 Issue 22 e01054-21
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eluted in high-imidazole buffer or soluble DYKDDDDK(3) peptide for Ni afﬁnity or antiFlag puriﬁcation approaches, respectively.
Elution of antibody-bound protein complexes in the presence of DYKDDDDK(3)
soluble peptide yielded highly pure samples containing both L and NP (Fig. 5B). Wildtype and catalytically inactive L copuriﬁed with NP at comparable abundances (Fig. 5B,
lanes 3 and 5). Complex elution from cells expressing the minireplicon RNA and NP
alone did not yield either L or NP (Fig. 5B, lane 7). In contrast, the imidazole-eluted
samples contained background levels of highly abundant copurifying proteins (Fig. 5B,
lanes 2, 4, and 6). These results demonstrate that antibody-mediated afﬁnity puriﬁcation of MACV L from functional RNP-expressing cells yields highly pure L and NP.
Negative-staining and transmission electron microscopy (negative-stain EM) analyses of peptide-eluted samples from wild-type L-expressing cells (Fig. 5B, lane 2)
revealed abundant monodispersed particles consistent with other negatively stained
images of NSV polymerases (Fig. 5C) (74, 75, 80). Compared with apo-MACV L puriﬁed
from insect cells, the eluted L-NP sample contained particles that were notably larger
and more compacted and globular in shape (Fig. 5C). These observations are generally
consistent with heterodimeric L-NP (;310 kDa) or heterotrimeric L-NP-NP (;380 kDa)
relative to monomeric L alone (;250 kDa), with possible rearrangements of the ﬂexible
N- and C-terminal endonuclease and cap-binding domains of L, respectively (21, 74).
These results demonstrate that afﬁnity-puriﬁed L and NP form monodispersed particles
of slightly larger size than puriﬁed L alone.
MACV RNPs are isolated in a pH-dependent manner. During puriﬁcation optimization, we tested variations of buffer conditions for elution of the L-NP complex. Final
elutions performed at neutral pH (7.0) yielded predominantly monodispersed particles,
November 2021 Volume 95 Issue 22 e01054-21
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FIG 4 L and NP coimmunoprecipitate from RNP-expressing cells. Polyacrylamide-SDS gels with total
proteins from the cell lysate input (left) and immunoprecipitated complexes (right) were run in
parallel for Coomassie staining (top) and immunoblotting analyses (bottom). Amounts of pL plasmid
transfected into cells included 0, 2, 4, 6, and 8 m g corresponding to the last ﬁve lanes of each gel.
Truncated or nonspeciﬁc proteins detected by the anti-MACV L polyclonal antisera are illustrated with
an asterisk (*). BSA, bovine serum albumin; HC, heavy chain of the anti-MACV L antibodies; NT,
nontransfected negative-control cells.

Journal of Virology

FIG 5 Afﬁnity puriﬁcation of monomeric L-NP from RNP-expressing cells. (A) Transfected cells expressing functional MACV RNP
components accumulate eGFP over the course of 72 h posttransfection (hpt). Cells transfected with wild-type (pLWT) or
catalytically inactive (pLSDD) L, in combination with pNP and pMG, are shown by ﬂuorescence (top) and bright-ﬁeld (bottom)
microscopy images for each condition at 24, 48, and 72 hpt. (B) Afﬁnity puriﬁcation of MACV L from the cells shown in panel A at
72 hpt. MACV L was puriﬁed from BSR-T7 cells as described in Materials and Methods. Lanes: N, ﬁnal elution from Ni-NTA
puriﬁcation; F, ﬁnal elution from anti-Flag antibody-mediated puriﬁcation. (C) Negative-stain EM images of apo-L puriﬁed from
insect cells and monodispersed L-NP complexes puriﬁed from BSR-T7 cells. Selected regions of the micrographs (white outlined
boxes) are shown magniﬁed to the right of the L and L-NP particle images.

as observed by negative-stain EM (Fig. 5C and 6A). In general, elution of the L-NP complex in solutions with pH ranging from moderately acidic (pH 5.5) to mildly alkaline
(pH 8.5) yielded mostly single particles, with some larger-order structures and aggregates observed (Fig. 6B). Samples puriﬁed at pH 8.0, however, consistently contained
ﬂexible RNP-like structures that were not observed under different buffer conditions
(Fig. 6B, fourth column, white arrowheads). These structures had a “beads on a string”like appearance, resembling shorter variations of puriﬁed RNPs from arenavirus (17–19,
81), orthobunyavirus (82, 83), and phlebovirus (84, 85) virions. These observations demonstrate that MACV RNP-like structures can be isolated from BSR-T7 cells in a pH-dependent manner, albeit at lower relative abundances than the monodispersed and
larger aggregated complexes.
MACV RNPs adopt diverse ﬂexible conformations. The MACV RNPs are categorized into three principal architectures: (i) medium to large circularized complexes
approximately 100 to 250 nm in diameter, (ii) medium-sized linear complexes approximately 100 to 200 nm long, or (iii) smaller ring-like complexes 30 to 40 nm in diameter
decorated with peripheral globular particles (Fig. 7A). The medium and larger complexes were also decorated with globular particles resembling monomeric L (Fig. 5C
and 7A). The different RNP classes do not adopt uniform conformations and instead
November 2021 Volume 95 Issue 22 e01054-21
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appear highly ﬂexible in solution. This ﬂexibility is highlighted by local curvatures of
the RNP ﬁlaments, adopting both linear and sharp-angled bends within a single complex (Fig. 7A and B). This inherent ﬁlament ﬂexibility is consistent with the RNP structures of other bunyaviruses (17–19, 81, 82, 84–86) and the uncoiled virion RNP of vesicular stomatitis virus (VSV) (Fig. 7B). Each RNP ﬁlament is approximately 10 nm in
diameter, which is nearly identical to the ﬁlament diameters of the Bunyamwera virus
(BUNV), Rift Valley fever virus (RVFV), and La Crosse virus (LACV) RNPs (82–85) and earlier EM images of arenavirus RNPs (18, 19, 81). Taken together, these observations
strongly suggest that the ﬂexible structures isolated from MACV RNP-expressing cells
represent authentic RNPs puriﬁed via the afﬁnity epitopes present in L.
MACV NP forms ring structures. In addition to the decorated ring-like structures
mentioned above, we also documented the formation of smaller circular structures
present in electron micrographs of the L-NP complexes puriﬁed by Ni afﬁnity chromatography (Fig. 3B and 8A). These smaller rings were approximately 10 to 20 nm in diameter and visually resembled the rings formed by LASV symmetric RNA-free NP
trimers in solution (Fig. 8B) (51). Other than aggregates and the crowded molecular
background on the EM grids (Fig. 8A), no large or higher-order structures were
observed in these samples. The Ni-afﬁnity elution was performed at near-neutral pH
(7.4), which could explain the lack of RNP-like complexes observed within these samples. Moreover, the L-NP samples contained additional proteins (Fig. 3B and 8A), suggesting that additional factors could inﬂuence the formation of NP rings in solution.
Taken together, these ﬁndings demonstrate that afﬁnity puriﬁcation of MACV L from
RNP-expressing cells can yield multiple copurifying subcellular complexes, including
monodispersed L-NP particles, higher-order RNP structures, and ring-like particles
resembling trimeric NP.
November 2021 Volume 95 Issue 22 e01054-21
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FIG 6 MACV RNPs are puriﬁed from BSR-T7 cells in a pH-dependent manner. (A) Representative micrographs of
monomeric L-NP particles puriﬁed at pH 7.0 by anti-Flag antibody-mediated afﬁnity puriﬁcation. (B) Representative
micrographs of complexes puriﬁed from RNP-expressing cells at pH 5.5 to 8.5. RNP-like structures puriﬁed at pH 8.0
are indicated by white arrowheads.

Journal of Virology

FIG 7 MACV intracellular RNPs adopt diverse ﬂexible structures. (A) The predominant classiﬁcations of MACV RNPs isolated from minireplicon-expressing
cells. White outlined boxes highlight the different classes of ﬂexible RNPs observed within a representative negative-stain EM micrograph. Examples of the
different classes (rings, circular, and open RNPs) are shown to the right of the micrograph. White arrowheads indicate positions of globular particles on the
periphery of the RNPs. (B) Comparison of the MACV RNP ﬁlaments with the virion RNP of vesicular stomatitis virus (VSV). White outlined boxes indicate
regions of ﬂexible RNP curvature, which are magniﬁed and shown to the right of each micrograph. White arrowheads in the magniﬁed boxes indicate
positions of globular particles on the periphery of the RNPs.

DISCUSSION
Here, we report a new approach for isolating and characterizing the principal core
replication machinery of Machupo virus. We utilized a cell-based minireplicon system
for MACV to assess the effects of afﬁnity tags introduced into L and NP on replication
and gene expression. Afﬁnity puriﬁcation of MACV L has yielded unexpected complexes of NP-bound L and RNP-like ﬁlamentous structures (Fig. 9A). These complexes,
which were puriﬁed from mammalian cells expressing an actively replicating MACV L,
present a foundation for future biochemical and structural analyses of arenavirus replication mechanisms. Moreover, this system provides an opportunity for further analyses
of the monomeric L-NP complex, for which there are no equivalent complexes for any
other NSV polymerase or nucleoprotein. This complex may inform our understanding
of transient nucleoprotein displacement during RNA synthesis and may provide insight
into the coordination of RNP assembly. All prior work on the physicochemical properties of arenavirus RNPs comes from characterization of these complexes from puriﬁed
virions of mildly pathogenic or nonpathogenic arenaviruses (i.e., Tacaribe virus and
Pichinde virus). Detailed analyses of the RNPs from hemorrhagic fever-causing mammarenaviruses are precluded by high biosafety containment requirements—all mammarenaviruses causing severe disease in humans, including MACV, are biosafety level 4
(BSL4) pathogens. Thus, cell-based arenavirus RNP systems are ideal for understanding
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FIG 8 Intracellular NP trimers associate with L. (A) Polyacrylamide-SDS gel from Fig. 3B shown to highlight the metal ion afﬁnity-puriﬁed
sample visualized in the negative-stain EM micrograph to the right. White boxes highlight representative ring-like structures, with additional
magniﬁed structures shown to the right of the micrograph. (B) Comparison of MACV NP rings to the previously characterized RNA-free rings
of LASV (right). A cartoon representation of the LASV NP crystal structure (PDB 3MX5) is overlaid on the MACV ring in the right-hand panel.
The LASV NP ring image on the far right is modiﬁed from Brunotte et al. (CC-BY 4.0) (51).

fundamental mechanisms of replication and may serve as a platform for drug screens
and development of targeted antiviral therapeutics.
L-NP association in cells. Concrete data and conclusions on the interactions
between arenavirus polymerase and nucleoproteins are lacking. It is currently not well
understood whether the L-NP interaction is direct, RNA mediated, or both at times.
Previous efforts characterizing interactions between L and NP from LCMV and LASV
demonstrated that virus-speciﬁc RNA was required for copuriﬁcation of L and NP, suggesting an indirect interaction mediated by RNA binding of both proteins (71). In contrast, expression and coimmunoprecipitation of L and NP in the absence of any viral RNA
have demonstrated a direct interaction between the two proteins (72, 73). For Tacaribe
virus, the L- and RNA-binding abilities of NP can be uncoupled via point mutagenesis,
and direct L binding appears to involve both N- and C-terminal regions of NP (70).
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Although we did not speciﬁcally test MACV L-NP association in the absence of any
expressed viral RNA, the copuriﬁcation of catalytically inactive L with NP suggests that
a processive polymerase with an intact and functional RdRP core is not required for NP
engagement. Whether the catalytically inactive mutant is defective in RNA binding is
also unknown; however, the identiﬁcation of secondary promoter binding sites on the
solvent-exposed surface of bunyavirus L proteins suggests that a functional active site
is not the only mode of RNA recognition by L (21, 87, 88). Thus, the L-NP interaction
observed here could also be mediated primarily by RNA, and the L-RNA-NP complexes
collapse upon changes in buffer pH in vitro to yield monodispersed single particles
(Fig. 6). Localized changes in pH could affect the assembly of arenavirus RTC puncta in
host cytosol, facilitating the association of newly translated NP with newly synthesized
RNA (58, 59, 89). Alternatively, L binding of the 39 and 59 untranslated RNA termini—
which are required for RNA-mediated L-NP association (71)—could induce a conformation of L that is amenable for NP engagement, such that the L-NP interaction is not
directly bridged by an RNA scaffold. This hypothesis is less likely, as virus-speciﬁc RNA
provided in trans failed to induce L-NP interactions (71).
Functions of the monomeric L-NP complex. While there is some debate about
whether L and NP interact directly during authentic arenavirus infections, the discrete
L-NP single-particle complexes identiﬁed here suggest that a direct interaction is at
least physiologically possible or perhaps mediated by very short RNA sequences. The
pH dependence of complex formation may also reﬂect a biochemical mechanism of
RNP assembly, whereby NP monomers preferentially associate with L or NP RNA under
neutral or mildly alkaline conditions, respectively. It is likely that arenavirus L and NP
must directly associate at some point during the processes of replication and transcription. Other NSVs utilize polymerase cofactors to coordinate transient displacement of
nucleoprotein monomers from the template during RNA synthesis (90–93). However,
arenaviruses and other NSVs with segmented genomes (e.g., other bunyaviruses and
orthomyxoviruses) do not encode analogous polymerase cofactors and thus utilize an
inherently different mechanism of nucleoprotein translocation. Whether this is directly
mediated by L and which domains of L are involved remain to be investigated. There is
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FIG 9 Model of arenavirus subcellular structures formed by L and NP during infection. (A) Illustration highlighting the diverse structures isolated from
MACV minireplicon-expressing BSR-T7 cells. (B) Proposed model for the role of a monomeric L-NP complex in RNP replication. (Step 1) A dimeric MACV L
structure is formed with one L subunit (left) serving as the active replicase and the other (right) bound to a single NP monomer waiting to receive the
nascent RNA from replicase L. (Step 2) As L begins elongation, the nascent 59 RNA is bound within the 59 ligand binding pocket of the adjacent inactive L
in a “hand-off” coordinated mechanism, stimulating this polymerase for subsequent RNA synthesis on the corresponding 39 promoter soon to be
synthesized (75). (Step 3) NP-bound L facilitates loading of the NP subunit onto the newly synthesized RNA. (Step 4) Soluble NP trimers are triggered to
reverse the gating mechanism of RNA binding, allowing for opening of the ring and engagement of the RNA. (Step 5) NP trimers are loaded onto the
growing RNP, either three at a time (depicted here) or one by one.
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also the question of the number of NP subunits per liter—whether L transiently displaces NP one or two subunits at a time, disrupting the interactions between adjacent
monomers, or whether the oligomeric NP-NP interactions remain undisturbed as L
slides underneath the intact chain to access the liberated RNA template. Future structural efforts aimed at characterizing this monomeric L-NP complex will provide insight
into the nature of these interactions.
Alternatively, monomeric L-NP could represent a functionally inactive complex,
primed to receive the growing nascent RNA from an adjacent replicase L-RNP.
Structural studies of the inﬂuenza virus replication machinery suggest that polymerase
dimerization facilitates the assembly of progeny RNPs by a product “hand-off” strategy
(94). According to this model, the nascent 59 RNA emerging from an actively replicating polymerase is bound by the adjacent quiescent polymerase, seeding NP deposition
onto the newly synthesized RNA and eventually resulting in the formation of a progeny
polymerase-bound RNP segment. Perhaps, the adjacent nonreplicating polymerase is
preloaded with an NP monomer to initiate this process of RNP assembly. In support of
this hypothesis, inﬂuenza NP interacts directly with the polymerase PB2 subunit without a requirement for viral RNA, and binding occurs near the site of polymerase dimerization (94–96). Moreover, MACV L dimerization occurs upon promoter RNA binding,
and mutation of the dimeric interface region disrupts RNA synthesis in vitro (21).
Collectively, this suggests that arenaviruses may also participate in a “hand-off” mode
of RNP replication and that monomeric L-NP could function on the receiving end of
the polymerase replication dimer to begin assembly of the new RNP segment (Fig. 9B).
These open questions require future biochemical and structural analyses of puriﬁed
arenavirus RNP components, like the complexes described in this study.
Proposed origins and functional consequences of diverse RNP structures. We
observed a heterogeneous population of ﬂexible MACV RNP structures, with ﬁlaments
of different sizes, shapes, and terminal connectivity (“open” versus “circular”) (Fig. 7).
The largest of these complexes could represent NP-bound full-length minireplicon
RNA (2,688 nucleotides [nt]), whereas the medium-sized “open” or “circular” segments
likely contain shorter RNAs of viral or cellular origin. Minireplicon truncation could
occur at secondary structures within the IGR during initial T7 RNAP synthesis. These
RNAs would be dead ends for L replication and transcription, as they would not contain the necessary 39 promoter motif for polymerase binding and initiation (74).
However, the presence of correct terminal 59 sequences could still guide L binding and
NP encapsidation of the RNA. The absence of a correct 39 promoter region would, however, preclude L engagement of both genome termini and pseudocircularization of the
RNP (74). This may explain the linear “open” RNPs observed in our samples (Fig. 7A).
The smaller ring-like RNPs (Fig. 7A) could contain truncated 59 RNAs from the minireplicon that are synthesized during L-mediated replication initiation. Like other
bunyaviruses and orthomyxoviruses, 59 RNA ligands from the viral genome segments
are important for stimulating the RNA synthesis activity of arenavirus L (75, 97).
Moreover, truncated RNAs corresponding to the 59 vRNA termini accumulate within
inﬂuenza virus-infected cells, and these short viral RNAs bind to the polymerase to activate replication in a segment-speciﬁc manner (98–100). Whether a related process
occurs for arenaviruses or other bunyaviruses remains unknown. Alternatively, these
ring-like structures could represent NP-encapsidated host or viral RNAs of a different
origin. Unbiased deep sequencing of RNPs puriﬁed from minireplicon-expressing and
arenavirus-infected host cells will clarify the nature and signiﬁcance of truncated RNAs
and RNP accumulation during infection.
All RNPs appear to be sparsely decorated with globular structures along the periphery of the ﬂexible ﬁlaments (Fig. 7, white arrowheads). The identity of these particles is
unknown; however, the consistent association with RNP structures implies some degree
of biological relevance. It is possible that these particles are monomeric L bound to
the surface of RNA-bound NP or directly to exposed RNA sequences within the RNP.
Similar structures are present attached to the puriﬁed RNPs of other arenaviruses and
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bunyaviruses (17, 18, 81–85). RNA-bound L in this case would either be stalled along
the template, actively synthesizing RNA, or bound to the minireplicon termini.
We also show that expression of the MACV Z protein can inhibit L-mediated replication and transcription of the minireplicon (Fig. 3C). The multifunctional arenavirus Z
protein is responsible for coordinating vRNPs into budding virion particles at the cell
surface (101) and direct inhibition of L catalytic activity (39). These roles have led to a
model whereby Z binding facilitates packaging and egress of transcriptionally primed
L with the vRNP segments. The effect of Z binding on the architecture of full RNPs
remains unknown. Recent cryo-EM structures of MACV, LASV, and Junin virus L-Z complexes further support the model of Z inhibiting RNA synthesis—either by allosteric inhibition of the L active site (102) or by steric blocking of the RNA product exit channel
(103). Our ﬁndings presented here offer a system to further probe the regulatory
effects of Z using an afﬁnity-tagged module for isolation of Z-bound RNPs (Fig. 3C).
Direct visualization of puriﬁed Z-bound RNPs by EM could offer insights into the relative position of inhibited L on the RNP and whether Z preferentially inhibits L in a promoter-bound, pre-elongation state or if inhibition is equally likely to occur at internal
sites of the minireplicon during active elongation.
The MACV NP ring-like structures (Fig. 8) likely represent the RNA-free “closed” multimeric form of NP, similar to the trimeric rings of other arenavirus NPs (51, 52, 54).
These closed rings are hypothesized to function like N0-P complexes for nonsegmented NSVs (91). Both structures involve occupation of the nucleoprotein RNA binding site to prevent nonspeciﬁc binding of nonviral RNAs in the cell. How these trimeric
NP structures form and then rearrange to accept RNA remains a mystery. One possibility is that newly translated NP subunits in proximity, possibly synthesized by polysomes (104), could assemble three at a time in the absence of RNA in the “closed” conformation. Then upon association with L, newly synthesized viral RNA, or a change in
local pH, the gating mechanism is triggered to induce opening of the ring and rearrangement of the tertiary structure at the RNA binding site. The three linked NP monomers could be added to the same RNA, like the proposed model for inﬂuenza virus
RNA encapsidation by preformed NP dimers (105–107), or added sequentially to the
same or separate RNAs.
Model of arenavirus L-NP interactions during replication and transcription. The
above observations have led to a proposed model for the subcellular structures formed
by L, NP, and viral RNA during arenavirus infections (Fig. 9). L-mediated replication
results in formation of ﬂexible NP-bound vRNP and cRNP structures within the cytoplasmic RTC puncta. Some of these structures are truncated and unsuitable templates
for replication or transcription but may play other roles in viral recombination and segmentation, defective particle formation, or stimulation of host immune responses
(Fig. 9A). Soluble L is likely bound directly to a subset of NP forming monodispersed
single particles—possibly inﬂuenced by localized changes in pH—which could function adjacent to an active replicase to seed growth of a newly synthesized RNP.
Trimeric NP rings in the cytoplasm adopting a “closed” conformation, incompatible
with RNA binding, are prevented from nonspeciﬁc encapsidation of host RNAs. An
unknown trigger induces the gating conformational switch opening the NP ring and
allowing the subunits to bind nascent RNA and assemble into new RNPs (Fig. 9B).
In summary, we present the ﬁrst structural analysis of subcellular complexes formed
by the MACV replication machinery in mammalian cells. These ﬁndings provide a foundation for functional and structural analyses of these megadalton assemblies, expanding our understanding of arenavirus L-NP interactions and the assembly of infectious
RNPs. Moreover, the cell-based MACV minireplicon presents a unique strategy for
advanced biochemical screens to identify essential host factors involved in RNP function and for inhibitors of the RNP assembly process.
MATERIALS AND METHODS
Cells and viruses. BSR-T7/5 cells were used for all MACV RNP experiments and were grown in
humidiﬁed incubators with 5% CO2 at 37 or 34°C as indicated. BSC-40 cells were used for ampliﬁcation
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of recombinant vaccinia virus. All mammalian cells were maintained using Dulbecco’s modiﬁed Eagle’s
medium (DMEM; Corning) supplemented with glucose, L-glutamine, sodium pyruvate, and 10% fetal bovine serum (FBS). Spodoptera frugiperda insect cells (Sf21) were maintained in spinner ﬂasks at 27°C in
TC100 medium (Gibco) supplemented with 10% FBS and used for expression of apo-MACV L as
described previously (39, 74, 75). T7 RNA polymerase-expressing vaccinia virus (vTF7-3) was ampliﬁed on
BSC-40 cells and titrated on BSR-T7/5 cells (78, 79). Recombinant vesicular stomatitis virus (VSV) was rescued from cDNA in BSR-T7/5 cells as described previously (108), using T7 RNAP expression plasmids for
N, P, L, and G and an eGFP-expressing an infectious genomic cDNA clone of the VSV Indiana serotype.
Crude supernatant stocks of VSV from BSR-T7/5 cells infected at a multiplicity of infection (MOI) of 0.1
and harvested at 12 h postinfection were used for the negative-stain EM experiments in Fig. 7B.
MACV minireplicon cloning and cell expression. The original pGEM3-based vector for T7 RNAPdriven expression of wild-type MACV L (strain Carvallo; GenBank accession no. AAT40450.1) (74) was
modiﬁed to include afﬁnity tags at the C terminus of L (Fig. 1B). New coding sequences corresponding
to the peptide GGDYKDDDDKGGHHHHHH were inserted between the E2209 and stop codon of L,
where the Flag and 6His afﬁnity tags are represented in boldface and underlined text, respectively,
separated by glycine linkers. The entire MACV L-Flag-6His open reading frame was also cloned into an
empty pCAGGS vector for the Pol II expression experiments (Fig. 2 and 4). The same cloning steps were
performed for a catalytically inactive mutant of L (SDD1328AAA) to generate the pLSDD plasmids.
Additionally, wild-type MACV NP (strain Carvallo; GenBank accession no. AAN05426.1) was cloned into
empty pGEM3 and pCAGGS vectors (pNP) for the T7 RNAP and Pol II experiments, respectively, and supplemented during transfections with the L-expressing (pL) and minireplicon RNA-expressing (pMG) vectors described below (Fig. 2A). A pcDNA3.1-based vector was used to express NP with a C-terminal V5 afﬁnity tag (GKPIPNPLLGLDST) for the experiments performed in Fig. 3C.
The MACV minireplicon assays were performed essentially as described previously, with minor modiﬁcations (39, 74). BSR-T7 cells at 95% conﬂuence in 60-mm-diameter dishes were infected with vaccinia
virus vTF7-3 at an MOI of 3 for 1 h at 37°C to supplement endogenous expression levels of T7 RNAP.
After infection, plasmids pL, pNP, and pMG were delivered into cells using 20 m l of Lipofectamine 2000
(Invitrogen) in 1.5 ml Opti-MEM following the standard transfection protocol provided by the manufacturer. For the L immunoprecipitation experiments (Fig. 4), the amount of transfected pL plasmid varied
from 0 to 8 m g per condition. For the experiments described in Fig. 3B, each 60-mm dish received 2 m g
and 4 m g of the pGEM3-based pL and pNP plasmids, respectively, plus 6 m g of the pMG T7 RNAP-driven
plasmid for expression of the minireplicon RNA. The same amounts of plasmid were used for the experiments in Fig. 2B, with pGEM3 and pCAGGS plasmids used for the T7 RNAP and Pol II expression conditions, respectively. The plasmid ratios were adjusted for the experiments shown in Fig. 5 based on the
immunoprecipitation data, with 4 m g pL, 2 m g pNP, and 6 m g pMG used for each transfection condition.
After 4 to 5 h of transfection, the Lipofectamine–Opti-MEM medium was replaced with DMEM supplemented with 2% FBS, and cells were maintained at 34°C. Cells were imaged at 24, 48 (Fig. 2 and 3), and
72 h (Fig. 5) posttransfection by ﬂuorescence microscopy to visually assess eGFP expression from the
MACV RNP.
MACV L antibody production. Full-length MACV L was puriﬁed from insect cells as described previously (74, 75) and used for production of polyclonal sera. Puriﬁed MACV L was supplied to the antibody
production service company (Covance Research Products) at a ﬁnal concentration of 0.4 mg/ml in a mixture of 50 mM HEPES, 0.5 M NaCl, and 10% glycerol at pH 7.5. MACV L antisera was produced by a single
animal (a New Zealand White rabbit) with an initial subcutaneous injection (250 m g) and three boosts
(125 m g each) of puriﬁed MACV L over the course of 63 days, followed by production bleeds at 73 and
77 days, respectively.
L-NP immunoprecipitation and immunoblotting. Following RNP expression, conﬂuent BSR-T7
cells were removed from each 60-mm dish using sterile cell scrapers, washed twice with 1 phosphatebuffered saline (PBS: 4.3 mM Na2HPO4, 1.47 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl [pH 7.4]), and resuspended in 0.75 ml of cold 1 PBS and kept on ice. One-third of the total resuspended cell volume
(0.25 ml) was mixed 1:1 (vol/vol) with cold 2 lysis buffer (20 mM Tris-HCl, 132 mM EDTA, 2% Nonidet P40, 0.8% sodium deoxycholate [pH 7.4]) and incubated on a tube rotator at 4°C for 30 min. After lysis,
the ;0.5-ml crude lysate was centrifuged at maximum speed in a refrigerated tabletop centrifuge for 10
min. The supernatant was collected and used for subsequent MACV L immunoprecipitation and immunoblotting. All buffers were prepared with a supplemented broad-spectrum protease inhibitor cocktail
(Sigma).
To immunoprecipitate MACV L from BSR-T7 cells, clariﬁed lysate (489 m l) from the steps described
above was incubated with 5 m l of 10% SDS (0.1% ﬁnal concentration), 5 m l of 100 (10 mg/ml) bovine
serum albumin (BSA), and 1 m l of anti-MACV L antiserum (1:500 ﬁnal dilution). The lysate-antiserum mixture was incubated on a tube rotator at 4°C for 2 h to allow antibody-L binding. The lysate-antibody mixture was then incubated overnight with 25 m l of prewashed protein A-agarose resin (Sigma). After overnight incubation, the protein A resin was pelleted and washed twice with cold 1 PBS supplemented
with 0.1% SDS. The ﬁnal ;25 m l of washed resin was mixed 1:1 with 1 PBS and used for subsequent
immunoblotting analyses.
For immunoblotting analyses, 12.5 m l of each input lysate or resuspended immunoprecipitated sample was mixed with 12.5 m l of 2 SDS loading buffer (100 mM Tris-HCl, 200 mM b -mercaptoethanol, 4%
SDS, 0.2% bromophenol blue, 20% glycerol [pH 6.8]) and boiled for 5 min. Sample tubes were centrifuged at maximum speed for 1 min to collect condensation, and 10 m l of each sample was loaded onto
a 7.5% polyacrylamide–SDS gel. Gels were run in duplicate for Coomassie staining and immunoblotting
using standard equipment (Bio-Rad). For immunoblotting, total separated proteins were transferred
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